tiprankstipranks
Biontech Se Sponsored Adr (DE:22UA)
NASDAQ:22UA
Germany Market
22UA
BioNTech SE
RESEARCH TOOLSreports

BioNTech SE (22UA) Stock Forecast & Price Target

53 Followers
See the Price Targets and Ratings of:

22UA Analyst Ratings

Strong Buy
16Ratings
Strong Buy
14 Buy
2 Hold
0 Sell
Based on 16 analysts giving stock ratings to
BioNTech
SE
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

22UA Stock 12 Month Forecast

Average Price Target

€117.26
▲(51.11% Upside)
Based on 16 Wall Street analysts offering 12 month price targets for BioNTech SE in the last 3 months. The average price target is €117.26 with a high forecast of €146.36 and a low forecast of €80.45. The average price target represents a 51.11% change from the last price of €77.60.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"76":"€76","147":"€147","93.75":"€93.8","111.5":"€111.5","129.25":"€129.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":146.35849815,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€146.36</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":117.25797805,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€117.26</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":80.4543791,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€80.45</span>\n  </div></div>","useHTML":true}}],"tickPositions":[76,93.75,111.5,129.25,147],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2025","6":"Oct<br/>2025","9":"Jan<br/>2026","12":"Apr<br/>2026","25":"Apr<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,77.65,82.93526908846154,88.22053817692309,93.50580726538462,98.79107635384617,104.0763454423077,109.36161453076923,114.64688361923078,119.93215270769231,125.21742179615384,130.5026908846154,135.7879599730769,141.07322906153846,{"y":146.35849815,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,77.65,80.6967675423077,83.74353508461539,86.79030262692308,89.83707016923077,92.88383771153846,95.93060525384615,98.97737279615384,102.02414033846154,105.07090788076923,108.11767542307692,111.16444296538461,114.21121050769231,{"y":117.25797805,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,77.65,77.86572146923078,78.08144293846155,78.2971644076923,78.51288587692308,78.72860734615385,78.94432881538462,79.16005028461538,79.37577175384615,79.59149322307692,79.8072146923077,80.02293616153845,80.23865763076923,{"y":80.4543791,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":84.9,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 43,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":91.2,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 57,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":99.4,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 58,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":91.6,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 48,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":92.05,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":86.2,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 28, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.65,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 44, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":89.2,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 39, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":84.95,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 32, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.35,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 38, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":93.4,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":93.85,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 52, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":77.65,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€146.36Average Price Target€117.26Lowest Price Target€80.45
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on DE:22UA
Mohit Bansal
Wells Fargo
Wells Fargo
€129.81
Buy
67.28%
Upside
Assigned
04/02/26
Wells Fargo Issues a Buy Rating on BioNTech SE (BNTX)
H.C. Wainwright Analyst forecast on DE:22UA
Robert Burns
H.C. Wainwright
H.C. Wainwright
€121.16→€112.5
Buy
44.98%
Upside
Reiterated
03/31/26
BioNTech price target lowered to $130 from $140 at H.C. WainwrightBioNTech price target lowered to $130 from $140 at H.C. Wainwright
Jefferies Analyst forecast on DE:22UA
Akash Tewari
Jefferies
Jefferies
€119.43
Buy
53.90%
Upside
Reiterated
03/25/26
Analysts Offer Insights on Healthcare Companies: BioNTech SE (NASDAQ: BNTX) and Biomea Fusion (NASDAQ: BMEA)
Deutsche Bank Analyst forecast on DE:22UA
Emmanuel Papadakis
Deutsche Bank
Deutsche Bank
€121.16
Buy
56.13%
Upside
Reiterated
03/17/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Morgan Stanley Analyst forecast on DE:22UA
Terence Flynn
Morgan Stanley
Morgan Stanley
€108.18
Buy
39.40%
Upside
Reiterated
03/16/26
Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (NASDAQ: ASND), Stevanato Group (NYSE: STVN) and BioNTech SE (NASDAQ: BNTX)
Truist Financial Analyst forecast on DE:22UA
Asthika Goonewardene
Truist Financial
Truist Financial
€134.14
Buy
72.86%
Upside
Reiterated
03/13/26
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF), BioNTech SE (NASDAQ: BNTX) and Skye Bioscience (NASDAQ: SKYE)
TD Cowen Analyst forecast on DE:22UA
Yaron Werber
TD Cowen
TD Cowen
€100.39→€81.35
Hold
4.83%
Upside
Assigned
03/11/26
Balancing Near-Term Headwinds and Strategic Transition: Why a Hold Rating Remains Warranted
Evercore ISI Analyst forecast on DE:22UA
Cory Kasimov
Evercore ISI
Evercore ISI
€112.5
Buy
44.98%
Upside
Reiterated
03/11/26
Evercore ISI Remains a Buy on BioNTech SE (BNTX)
Citi Analyst forecast on DE:22UA
Geoff Meacham
Citi
Citi
€125.49→€112.5
Buy
44.98%
Upside
Reiterated
03/11/26
BioNTech price target lowered to $130 from $145 at CitiBioNTech price target lowered to $130 from $145 at Citi
BMO Capital Analyst forecast on DE:22UA
Evan Seigerman
BMO Capital
BMO Capital
€123.76→€110.77
Buy
42.75%
Upside
Reiterated
03/11/26
BioNTech price target lowered to $128 from $143 at BMO CapitalBioNTech price target lowered to $128 from $143 at BMO Capital
Clear Street Analyst forecast on DE:22UA
William Maughan
Clear Street
Clear Street
€156.64→€144.53
Buy
86.24%
Upside
Reiterated
03/11/26
Analysts Offer Insights on Healthcare Companies: Senseonics Holdings (NASDAQ: SENS) and BioNTech SE (NASDAQ: BNTX)
Goldman Sachs Analyst forecast on DE:22UA
Asad Haider
Goldman Sachs
Goldman Sachs
€125.49→€114.24
Buy
47.21%
Upside
Reiterated
03/11/26
BioNTech SE (BNTX) Receives a Buy from Goldman Sachs
Canaccord Genuity Analyst forecast on DE:22UA
John Newman
Canaccord Genuity
Canaccord Genuity
€147.99
Buy
90.70%
Upside
Reiterated
03/11/26
Canaccord Genuity Reaffirms Their Buy Rating on BioNTech SE (BNTX)
Leerink Partners Analyst forecast on DE:22UA
Daina Graybosch
Leerink Partners
Leerink Partners
€97.79
Hold
26.02%
Upside
Downgraded
02/02/26
BioNTech downgraded to Market Perform from Outperform at LeerinkBioNTech downgraded to Market Perform from Outperform at Leerink
Bank of America Securities Analyst forecast on DE:22UA
Tazeen Ahmad
Bank of America Securities
Bank of America Securities
€115.97
Buy
49.44%
Upside
Reiterated
01/30/26
Bank of America Securities Remains a Buy on BioNTech SE (BNTX)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wells Fargo Analyst forecast on DE:22UA
Mohit Bansal
Wells Fargo
Wells Fargo
€129.81
Buy
67.28%
Upside
Assigned
04/02/26
Wells Fargo Issues a Buy Rating on BioNTech SE (BNTX)
H.C. Wainwright Analyst forecast on DE:22UA
Robert Burns
H.C. Wainwright
H.C. Wainwright
€121.16→€112.5
Buy
44.98%
Upside
Reiterated
03/31/26
BioNTech price target lowered to $130 from $140 at H.C. WainwrightBioNTech price target lowered to $130 from $140 at H.C. Wainwright
Jefferies Analyst forecast on DE:22UA
Akash Tewari
Jefferies
Jefferies
€119.43
Buy
53.90%
Upside
Reiterated
03/25/26
Analysts Offer Insights on Healthcare Companies: BioNTech SE (NASDAQ: BNTX) and Biomea Fusion (NASDAQ: BMEA)
Deutsche Bank Analyst forecast on DE:22UA
Emmanuel Papadakis
Deutsche Bank
Deutsche Bank
€121.16
Buy
56.13%
Upside
Reiterated
03/17/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Morgan Stanley Analyst forecast on DE:22UA
Terence Flynn
Morgan Stanley
Morgan Stanley
€108.18
Buy
39.40%
Upside
Reiterated
03/16/26
Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (NASDAQ: ASND), Stevanato Group (NYSE: STVN) and BioNTech SE (NASDAQ: BNTX)
Truist Financial Analyst forecast on DE:22UA
Asthika Goonewardene
Truist Financial
Truist Financial
€134.14
Buy
72.86%
Upside
Reiterated
03/13/26
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF), BioNTech SE (NASDAQ: BNTX) and Skye Bioscience (NASDAQ: SKYE)
TD Cowen Analyst forecast on DE:22UA
Yaron Werber
TD Cowen
TD Cowen
€100.39→€81.35
Hold
4.83%
Upside
Assigned
03/11/26
Balancing Near-Term Headwinds and Strategic Transition: Why a Hold Rating Remains Warranted
Evercore ISI Analyst forecast on DE:22UA
Cory Kasimov
Evercore ISI
Evercore ISI
€112.5
Buy
44.98%
Upside
Reiterated
03/11/26
Evercore ISI Remains a Buy on BioNTech SE (BNTX)
Citi Analyst forecast on DE:22UA
Geoff Meacham
Citi
Citi
€125.49→€112.5
Buy
44.98%
Upside
Reiterated
03/11/26
BioNTech price target lowered to $130 from $145 at CitiBioNTech price target lowered to $130 from $145 at Citi
BMO Capital Analyst forecast on DE:22UA
Evan Seigerman
BMO Capital
BMO Capital
€123.76→€110.77
Buy
42.75%
Upside
Reiterated
03/11/26
BioNTech price target lowered to $128 from $143 at BMO CapitalBioNTech price target lowered to $128 from $143 at BMO Capital
Clear Street Analyst forecast on DE:22UA
William Maughan
Clear Street
Clear Street
€156.64→€144.53
Buy
86.24%
Upside
Reiterated
03/11/26
Analysts Offer Insights on Healthcare Companies: Senseonics Holdings (NASDAQ: SENS) and BioNTech SE (NASDAQ: BNTX)
Goldman Sachs Analyst forecast on DE:22UA
Asad Haider
Goldman Sachs
Goldman Sachs
€125.49→€114.24
Buy
47.21%
Upside
Reiterated
03/11/26
BioNTech SE (BNTX) Receives a Buy from Goldman Sachs
Canaccord Genuity Analyst forecast on DE:22UA
John Newman
Canaccord Genuity
Canaccord Genuity
€147.99
Buy
90.70%
Upside
Reiterated
03/11/26
Canaccord Genuity Reaffirms Their Buy Rating on BioNTech SE (BNTX)
Leerink Partners Analyst forecast on DE:22UA
Daina Graybosch
Leerink Partners
Leerink Partners
€97.79
Hold
26.02%
Upside
Downgraded
02/02/26
BioNTech downgraded to Market Perform from Outperform at LeerinkBioNTech downgraded to Market Perform from Outperform at Leerink
Bank of America Securities Analyst forecast on DE:22UA
Tazeen Ahmad
Bank of America Securities
Bank of America Securities
€115.97
Buy
49.44%
Upside
Reiterated
01/30/26
Bank of America Securities Remains a Buy on BioNTech SE (BNTX)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering BioNTech SE

3 Months
xxx
Success Rate
11/25 ratings generated profit
44%
Average Return
+0.84%
reiterated a xxx
 rating 9 days ago
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 3 Months would result in 44.00% of your transactions generating a profit, with an average return of +0.84% per trade.
1 Year
Robert BurnsH.C. Wainwright
Success Rate
12/25 ratings generated profit
48%
Average Return
-0.50%
reiterated a buy rating 9 days ago
Copying Robert Burns's trades and holding each position for 1 Year would result in 48.00% of your transactions generating a profit, with an average return of -0.50% per trade.
2 Years
xxx
Success Rate
10/25 ratings generated profit
40%
Average Return
-6.03%
reiterated a xxx
 rating 9 days ago
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 2 Years would result in 40.00% of your transactions generating a profit, with an average return of -6.03% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

22UA Analyst Recommendation Trends

Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
8
7
4
7
8
Buy
30
31
20
20
12
Hold
32
38
31
52
31
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
70
76
55
79
51
In the current month, 22UA has received 20 Buy Ratings, 31 Hold Ratings, and 0 Sell Ratings. 22UA average Analyst price target in the past 3 months is 117.26.
Each month's total comprises the sum of three months' worth of ratings.

22UA Financial Forecast

22UA Earnings Forecast

Next quarter’s earnings estimate for 22UA is -€2.20 with a range of -€3.01 to -€1.33. The previous quarter’s EPS was -€1.25. 22UA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 22UA has Performed in-line its overall industry.
Next quarter’s earnings estimate for 22UA is -€2.20 with a range of -€3.01 to -€1.33. The previous quarter’s EPS was -€1.25. 22UA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 22UA has Performed in-line its overall industry.

22UA Sales Forecast

Next quarter’s sales forecast for 22UA is €185.40M with a range of €108.89M to €343.70M. The previous quarter’s sales results were €903.96M. 22UA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 22UA has Performed in-line its overall industry.
Next quarter’s sales forecast for 22UA is €185.40M with a range of €108.89M to €343.70M. The previous quarter’s sales results were €903.96M. 22UA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 22UA has Performed in-line its overall industry.

22UA Stock Forecast FAQ

What is DE:22UA’s average 12-month price target, according to analysts?
Based on analyst ratings, Biontech Se Sponsored Adr’s 12-month average price target is 117.26.
    What is DE:22UA’s upside potential, based on the analysts’ average price target?
    Biontech Se Sponsored Adr has 51.11% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Biontech Se Sponsored Adr a Buy, Sell or Hold?
          Biontech Se Sponsored Adr has a consensus rating of Strong Buy, which is based on 14 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Biontech Se Sponsored Adr’s share price target?
            The average share price target for Biontech Se Sponsored Adr is 117.26. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €146.36 ,and the lowest forecast is €80.45. The average share price target represents 51.11% Increase from the current price of €77.6.
              What do analysts say about Biontech Se Sponsored Adr?
              Biontech Se Sponsored Adr’s analyst rating consensus is a Strong Buy. This is based on the ratings of 16 Wall Streets Analysts.
                How can I buy shares of Biontech Se Sponsored Adr?
                To buy shares of DE:22UA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.